CDC Report Tracks 19 Major Drug-Resistant Pathogens

The latest analysis identifies major infection risks and rising threats to public health across the United States.

Updated on Oct. 27, 2026 in COVID-19

Isometric editorial illustration of sterile laboratory culture dishes arranged on a table, representing the study of drug-resistant pathogens. — The CDC's 2026 report on antibiotic-resistant pathogens tracks 19 major infection risks responsible for 9.7 million annual cases in the United States. AI Illustration. Upload story photo >

Live Poll

Do you trust the U.S. healthcare system to effectively manage the rise of drug-resistant infections?

The Centers for Disease Control and Prevention released its 2026 AR Threats Report, identifying 19 drug-resistant pathogens that cause 9.7 million infections annually in the United States. These resistant germs result in approximately 50,800 deaths each year, highlighting ongoing challenges in infection prevention and management.

Why it matters

Understanding the current landscape of drug-resistant pathogens is critical for patients and caregivers navigating hospital safety and long-term care decisions. By tracking these trends, public health officials identify which infections pose the most significant risk to the U.S. population.

The CDC report tracks 19 drug-resistant pathogens, noting that 9.7 million infections lead to 50,800 deaths annually. While Candida auris infections have increased tenfold since 2019, Clostridioides difficile rates dropped 21% between 2018 and 2020.

The players

Centers for Disease Control and Prevention

The federal agency responsible for protecting public health by tracking disease outbreaks and implementing prevention strategies.

The details

Drug-resistant germs often share genetic resistance through mobile genetic elements, which allow bacteria to transfer defense mechanisms against antibiotics. Improvements in rates for pathogens like Clostridioides difficile are attributed to stronger infection prevention protocols, better antibiotic stewardship, and increased use of diagnostic testing. Conversely, new threats such as Neisseria meningitidis require ongoing monitoring to track emerging resistance patterns.

2018-2020: Clostridioides difficile infection rates declined by 21%.
2019: This year serves as the baseline for the tenfold increase in Candida auris infections.
2023: Health care-associated infections caused over 42,000 deaths and nearly $12 billion in costs.
2026: The Centers for Disease Control and Prevention released the AR Threats Report.

Health Landscape

The 2026 report marks an evolution in how health officials track the threat of antimicrobial resistance. It updates the classification of common pathogens to better reflect the changing risks in clinical and community settings.

Patients and families should be aware that health care-associated infections caused over 42,000 deaths in 2023, making it vital to discuss hospital safety protocols with a physician. Always ask about infection control measures when planning for surgeries or long-term care stays.

The takeaway

Drug resistance remains a significant health risk, with 19 pathogens currently tracked for their ability to bypass standard treatments. Readers should prioritize conversations with their healthcare providers regarding infection prevention when accessing clinical facilities.